In this issue
During the European Respiratory Society (ERS) Congress held in Vienna, Austria, in September 2024, at a GSK-sponsored promotional symposium, leading experts discussed key considerations for selecting an inhaled corticosteroid (ICS)/long-acting β2-agonist
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Latest articles
All articles


We’ve noticed you’re accessing
from North/South America.
from North/South America.